| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8410 |
| Human Intestinal Absorption | HIA+ | 0.8357 |
| Caco-2 Permeability | Caco2- | 0.6109 |
| P-glycoprotein Substrate | Non-substrate | 0.5126 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9662 |
| Non-inhibitor | 0.9194 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9147 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8061 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7856 |
| CYP450 2D6 Substrate | Non-substrate | 0.8705 |
| CYP450 3A4 Substrate | Non-substrate | 0.6672 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7493 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8817 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9174 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9225 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8640 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9672 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9557 |
| Non-inhibitor | 0.9152 |
| AMES Toxicity | Non AMES toxic | 0.9414 |
| Carcinogens | Non-carcinogens | 0.8386 |
| Fish Toxicity | High FHMT | 0.5665 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.9174 |
| Honey Bee Toxicity | High HBT | 0.6019 |
| Biodegradation | Ready biodegradable | 0.9811 |
| Acute Oral Toxicity | III | 0.5080 |
| Carcinogenicity (Three-class) | Non-required | 0.7866 |